Allianz SE

Position in ABBV — AbbVie Inc.

CIK 1127508 Munich, 2M

Position in ABBV

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$21,080,385

+$4,788,210 QoQ

Shares Held

83,772

+11.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.57%

of 13F equity value

Holder Rank

#589

of 4,152 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Allianz SE holds $193,228,091 across 11 Drug Manufacturers - General names. ABBV ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	2,683,370	$64,615,548
2	LLY	ELI LILLY & Co	31,653	$37,965,558
3	JNJ	Johnson & Johnson	89,438	$22,714,568
4	ABBV	AbbVie Inc. This page	83,772	$21,080,385
5	AZN	Astrazeneca PLC	79,986	$15,166,944
6	MRK	Merck & Co., Inc.	112,208	$14,418,728
7	AMGN	Amgen Inc	31,246	$11,314,800
8	BMY	Bristol Myers Squibb Co	94,851	$5,465,313

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,080,385	83,772	+11.8%	Shares	Defined	2026-08-10
2026-03-31	$16,292,175	74,910	-23.0%	Shares	Defined	2026-05-11
2025-12-31	$22,219,508	97,245	+2.7%	Shares	Defined	2026-02-13
2025-09-30	$21,915,027	94,649	-0.4%	Shares	Defined	2025-11-12
2025-06-30	$17,643,365	95,051	-2.5%	Shares	Defined	2025-08-08
2025-03-31	$20,416,256	97,443	+2.0%	Shares	Defined	2025-05-09
2024-12-31	$16,981,011	95,560	-5.5%	Shares	Defined	2025-02-12
2024-09-30	$19,979,247	101,171	+27.2%	Shares	Defined	2025-05-12
2024-06-30	$13,638,069	79,513	-4.7%	Shares	Defined	2025-05-12
2024-03-31	$15,190,053	83,416	—	Shares	Defined	2025-05-12
No filing history on record for this holder in this stock.